Superior Planning, LLC’s IDEAYA Biosciences IDYA Stock Holding History

Superior Planning, LLC’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.15K	Buy	+30	New	+$1.13K	﹤0.01%	1719

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

GSK plc London $497M AUM 35.1% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Superior Planning, LLC's IDYA Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in IDEAYA Biosciences (IDYA) in Q3 2026: 30 shares worth $1.15K. The stake represents ﹤0.01% of the portfolio and ranks #1719 among its holdings.

162 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

Superior Planning, LLC held 30 shares of IDEAYA Biosciences worth $1.15K as of Q3 2026.
IDEAYA Biosciences was a new Superior Planning, LLC position in Q3 2026.
IDEAYA Biosciences made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1719 holding.
162 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.